clinical trial enrollment

https://www.prweb.com/releases/dia_2014_50th_annual_meeting_panel_to_explore_clinical_trial_enrollment_obstacles/prweb11850099.htm DIA 2014 50th Annual Meeting Panel to Explore Clinical Trial Enrollment Obstacles Washington (PRWEB) May 13, 2014 -- Experts dedicated to enhancing clinical trials will explore hurdles in patient enrollment at the DIA 2014 50th Annual... clinical trial enrollment annual meeting https://www.biospace.com/3spine-announces-completion-of-fda-clinical-trial-enrollment-achieving-325-surgeries-in-2023 3Spine Announces Completion of FDA Clinical Trial Enrollment Achieving 325 Surgeries in 2023 -... Jan 11, 2024 - 3Spine, Inc., a medical device company developing a transformational alternative to lumbar spinal fusion, today announced achievement of US clinical trial... clinical trial enrollment https://www.sas.com/en_gb/software/clinical-enrollment-simulation.html SAS Clinical Trial Enrollment Simulation | SAS UK SAS Clinical Enrollment Trial Simulation is a solution that uses powerful discrete event simulation to devise better projections for enrollment planning. clinical trial enrollment sas simulation uk https://gethealthkey.com/ Boost Clinical Trial Enrollment - HealthKey HealthKey is an AI-powered Patient Identification service for Clinical Trial Sites. We help identify and qualify patients fast by matching trials' eligibility... clinical trial enrollment boost https://www.techtarget.com/pharmalifesciences/news/366606733/Decentralization-Tools-May-Improve-Cancer-Clinical-Trial-Enrollment Decentralization Tools May Improve Cancer Clinical Trial Enrollment | TechTarget A recent investigation concluded that decentralizing clinical trials using remote technology and additional tools may help improve cancer clinical trial... clinical trial enrollment decentralization tools may improve https://www.prnewswire.co.uk/news-releases/dipexium-announces-completion-of-enrollment-objective-in-onestep-1-pivotal-phase-3-clinical-trial-579624801.html Dipexium Announces Completion of Enrollment Objective in OneStep-1 Pivotal Phase 3 Clinical Trial /PRNewswire/ -- Dipexium Pharmaceuticals, Inc. (Nasdaq: DPRX), a late-stage pharmaceutical company focused on the development and commercialization of... https://www.biospace.com/otonomy-inc-completes-enrollment-in-phase-ii-clinical-trial-for-auripro-in-pediatric-patients-with-acute-otitis-media-with-tympanostomy-tubes Otonomy, Inc. Completes Enrollment In Phase II Clinical Trial For Auripro In Pediatric Patients... https://www.prnewswire.com/news-releases/the-usher-syndrome-coalition-announces-partnership-with-proqr-to-support-clinical-trial-enrollment-for-a-potential-therapy-for-ush2a-mediated-retinitis-pigmentosa-301470693.html The Usher Syndrome Coalition announces partnership with ProQR to support clinical trial enrollment... /PRNewswire/ -- For more than ten years, the Usher Syndrome Coalition has been working to build its international "USH Trust" registry in anticipation of the... https://investingnews.com/zelda-therapeutics-completes-enrollment-for-latest-clinical-trial Zelda Therapeutics Completes Enrollment for Latest Clinical Trial | INN Jan 2, 2026 - Zelda Therapeutics (ASX:ZLD,OTCQB:ZLDAF) informed the market its clinical trial for medical cannabis treating insomnia completed its enrollment. As quoted in... clinical trial zelda therapeutics completes enrollment https://www.biospace.com/aegea-medical-completes-enrollment-in-the-pace-ii-clinical-trial AEGEA Medical Completes Enrollment in the Pace II Clinical Trial - BioSpace Jan 8, 2019 - Study is assessing uterine cavity access and projected intervention feasibility three to four years post endometrial vapor ablation for heavy menstrual bleeding in the clinical trial aegea medical completes https://www.businesswire.com/news/home/20260121338054/en/Concept-Medical-Announces-First-Patient-Enrollment-in-STARS-DAPT-Randomized-Clinical-Trial-Evaluating-Abluminus-NP-Polymer-Free-DES Concept Medical Announces First Patient Enrollment in STARS DAPT Randomized Clinical Trial... Concept Medical Inc. is proud to announce the successful enrollment of the first patients in the STARS DAPT randomized controlled trial. concept medical patient enrollment https://www.biospace.com/capricor-therapeutics-inc-completes-enrollment-of-phase-ii-clinical-trial-for-cenderitide-to-treat-heart-failure Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To... https://www.biospace.com/press-releases/nektar-therapeutics-announces-completion-of-target-enrollment-in-rezolve-ad-phase-2b-clinical-trial-of-rezpegaldesleukin-in-patients-with-moderate-to-severe-atopic-dermatitis Nektar Therapeutics Announces Completion of Target Enrollment in REZOLVE-AD Phase 2b Clinical Trial... https://finviz.com/news/172096/medicinova-announces-completion-of-patient-enrollment-in-combat-als-phase-2b3-clinical-trial-of-mn-166-ibudilast MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of... Stock screener for investors and traders, financial visualizations. https://investingnews.com/daily/life-science-investing/biotech-investing/ocugen-completes-50-percent-enrollment-in-phase-3-clinical-trial/ Ocugen Completes 50 Percent Enrollment in Phase 3 Clinical Trial | INN Jan 2, 2026 - Ocugen (NASDAQ:OCGN) has announced it has completed 50 percent of patient enrollment in its Phase 3 clinical trial of OCU300 for patients with ocular Graft... clinical trial completes percent enrollment https://www.biospace.com/cervomed-announces-completion-of-enrollment-in-phase-2b-rewind-lb-clinical-trial-of-neflamapimod-for-the-treatment-of-patients-with-dementia-with-lewy-bodies CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod... Jun 12, 2024 - CervoMed Inc., a clinical stage company focused on developing treatments for age-related neurologic disorders, announced that it has completed enrollment in... https://www.prnewswire.com/news-releases/perfuse-therapeutics-announces-initiation-of-enrollment-to-the-phase-2a-clinical-trial-of-per001-intravitreal-implant-in-diabetic-retinopathy-301892514.html?tc=eml_cleartime Perfuse Therapeutics Announces Initiation of Enrollment to the Phase 2A Clinical Trial of PER001... /PRNewswire/ -- Perfuse Therapeutics, a biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases is pleased... https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2019.00104/full Frontiers | The Impact of an Educational Video on Clinical Trial Enrollment and Knowledge in Ethnic... Introduction: Innovative methods to increase awareness about clinical trials and address barriers associated with low participation among racial/ethnic minor...

Robuta